Last update 22 Nov 2025

[68Ga]-PSMA-0057

Overview

Basic Info

Drug Type
Peptide Conjugate Radionuclide, Therapeutic radiopharmaceuticals
Synonyms
[68Ga]-PSMA-0057
Target
PSMA
Action
modulators
Mechanism
PSMA modulators(Prostate-specific membrane antigen modulators)
Therapeutic Areas
NeoplasmsUrogenital Diseases
Active Indication
PSMA-Positive Castration-Resistant Prostatic CancerPSMA-Positive Prostatic Cancer
Inactive Indication-
Originator Organization
Suzhou Ruihe Pharmaceutical Technology Co., Ltd.
Active Organization
Suzhou Ruihe Pharmaceutical Technology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

1
Clinical Trials associated with [68Ga]-PSMA-0057
CTR20254606
/ Not yet recruitingPhase 1/2
在PSMA阳性的转移性去势抵抗性前列腺癌患者中评价镓[68Ga]PSMA-0057注射液和镥[177Lu]PSMA-0057注射液的安全性、耐受性、临床药理学特征和初步有效性的单臂、开放、剂量递增及扩展的I/II期临床试验
[Translation] A single-arm, open-label, dose-escalation, and expansion phase I/II clinical trial evaluating the safety, tolerability, clinicophagus pharmacology, and preliminary efficacy of gallium [68Ga]PSMA-0057 injection and lutetium [177Lu]PSMA-0057 injection in patients with PSMA-positive metastatic castration-resistant prostate cancer.
100 Clinical Results associated with [68Ga]-PSMA-0057
Login to view more data
100 Translational Medicine associated with [68Ga]-PSMA-0057
Login to view more data
100 Patents (Medical) associated with [68Ga]-PSMA-0057
Login to view more data
100 Deals associated with [68Ga]-PSMA-0057
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
PSMA-Positive Castration-Resistant Prostatic CancerPhase 2
China
Suzhou Ruihe Pharmaceutical Technology Co., Ltd.
19 Nov 2025
PSMA-Positive Prostatic CancerIND Approval
China
Suzhou Ruihe Pharmaceutical Technology Co., Ltd.
30 Sep 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free